Heart Failure and Obesity Clinical Trials In Beltsville, MD
If you have preserved or mildly reduced heart function alongside obesity, you may qualify for heart failure and obesity clinical trials at Metropolitan Clinical Research (MCR).
Advancing Heart Health Through Clinical Trials of HFpEF and Obesity
About Heart Failure With Preserved Ejection Fraction
Heart failure with preserved or mildly reduced ejection fraction (HFpEF or HFmrEF) can cause breathlessness, fatigue, swelling, and difficulty with everyday activities. When obesity is also present, these challenges may become harder to manage and can increase the risk of worsening heart failure, urgent visits, or hospitalization.
Although standard care can help, some people still experience ongoing symptoms and complications, creating a need for additional treatment options. This heart failure and obesity research study is exploring a potential new treatment for people living with both conditions.
Interested in a Heart Failure & Obesity Research Study?
Complete this short form to see if you may qualify for a heart failure & Obesity research study.
🔒 Your information is securely handled and not shared outside the research team.
Looking Beyond Standard Care for Heart Failure and Obesity
This clinical trial is evaluating an investigational drug alongside standard heart-failure treatment in adults living with HFpEF or HFmrEF and obesity. Researchers want to see whether the study treatment can help reduce heart-failure hospitalizations, urgent visits, and cardiovascular deaths, while also improving heart-failure symptoms.
This study will also closely monitor participants’ health and safety to better understand how the investigational treatment may affect people living with obesity and cardiovascular disease.
Why Participate at Metropolitan Clinical Research (MCR)?
At Metropolitan Clinical Research (MCR), we bring clinical expertise and a dedicated, participant-focused approach to advancing cardiovascular research. Our experienced research team is focused on maintaining high standards of study conduct while putting participant safety first.
- When you participate in our heart failure and obesity clinical trials, you can expect:
- Experienced cardiovascular research professionals
- Regular monitoring of your health and safety
- Clear communication throughout the study
- Support during study visits and procedures
- A respectful and comfortable study environment
Whether you’re considering clinical trials of HFpEF and obesity or any other weight management study, our team is here to answer your questions and address any concerns you may have.
Why This Study Matters
Heart failure with preserved or mildly reduced ejection fraction, particularly when combined with obesity, can affect everyday life and increase the risk of worsening heart failure, urgent medical visits, and hospitalization. Although standard care can help manage these conditions, some people continue to experience symptoms and complications, creating a need for additional treatment options. This study is being conducted to explore a potential new treatment option for improving heart-failure-related outcomes.
By participating, you’ll receive study-related care and support while helping researchers explore new treatment possibilities for people living with heart failure and obesity.
Eligibility Criteria
Join our heart failure and obesity research study and help advance future care.
- Age Group
40 Years and older (Adult, Older Adult )
- Gender
Male & Female
- Study Status
Heart Failure
- Location
Beltsville, MD
Frequently Asked Questions
Answers to common questions about our clinical research.
What are heart failure and obesity clinical trials?
These studies investigate potential treatments for people managing both conditions. This study is evaluating whether an investigational treatment can reduce heart-failure-related events and improve symptoms.
Who may qualify for heart failure and obesity clinical trials in Beltsville, MD?
Adults with obesity and certain types of heart failure, including preserved or mildly reduced heart function, may be eligible. The study team will review specific eligibility requirements.
What happens during a heart failure and obesity research study?
Participants receive either the study treatment or placebo alongside standard care. The research team will monitor their health, symptoms, and safety throughout the study.
Is this a weight management study?
Not specifically. Weight is one aspect of the study participants, but the main focus is heart failure and its related health complications.
Where can I learn more about this clinical trial?
You can contact Metropolitan Cardiovascular Research (MCR) in Beltsville, MD, to learn more about the study, ask questions, and find out whether you may be eligible to participate.
Interested in Participating? We're Here to HelpÂ
Our team at Metropolitan Clinical Research is available to answer your questions and guide you through the next steps. Contact us today to learn more about our clinical research studies.